GL1X · GenesisL1 explorer

Ligand · Y7L

Y7L · N-{5-[5-(2-amino-4-oxo-3,4-dihydro-5H-pyrrolo[3,2-d]pyrimidin-5-yl)pentyl]thiophene-2-carbonyl}-L-glutamic acid

Y7L, N-{5-[5-(2-amino-4-oxo-3,4-dihydro-5H-pyrrolo[3,2-d]pyrimidin-5-yl)pentyl]thiophene-2-carbonyl}-L-glutamic acid (C21 H25 N5 O6 S, 475.5 g/mol), in the MolNFT structures on GenesisL1: bound in 1 record (1 PDB entry). Every binding site…

Component
Y7L
Formula
C21 H25 N5 O6 S
Class
ligand
Structures
1
PDB entries
1

Binding sites

Y7L in 1 structure; the first of them:

  • 8FJX · Human GAR transformylase in complex with GAR substrate and AGF320 inhibitor · Y7L A1101 · binds ARG871, LEU892, MET896, ARG897, ILE898, LEU899, VAL904, ASN913 and 7 more

Residues it binds most

VAL 1, ARG 1, LEU 1, ALA 1, ASN 1, GLU 1, GLY 1, HIS 1, ILE 1, MET 1 (residue and the binding sites it lines).

Found with

  • GAR · Glycinamide ribonucleotide

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.